Navigation Links
Inclinix Announces New Patent for Expert System Platform
Date:3/10/2008

WILMINGTON, N.C., March 10 /PRNewswire/ -- Inclinix, Inc., an enrollment contract research organization (CRO) and provider of clinical trial recruitment solutions, announced today that it has received a patent for its Expert System Platform (ESP). ESP is a software system that guides interview questions during patient qualification for clinical trials of new drugs or medical devices.

Inclinix advertises to recruit patients into clinical trials. Respondents to Inclinix advertising answer questions on a Web site or when interacting via phone with Inclinix TeleMEDICINE(TM) Contact Center representatives. The questions posed to respondents determine if the respondents fit the inclusion and exclusion criteria from the trial sponsor, usually a pharmaceutical company.

ESP dynamically organizes questions for the interview, changing question order or removing questions depending on the answers. ESP is particularly helpful for simultaneous trials. The system can automatically switch the prospective trial candidate to questions for a sponsor's second, third or fourth trial if he or she does not qualify for the first one.

ESP inventor and Inclinix Chief Operating Officer Chris Sleat said: "The way that the system is built turns the previous interviewing automation processes and logic on its head. With ESP, the data defines the screening logic, so users do not have to think about the structure or dependencies of the interview. ESP is vastly superior to a static interview script."

ESP includes the ability to leverage data from prior volunteers who have elected to be included in a database for consideration in future trials. EPS works well in combination with internal reporting systems.

ESP also supports novel medical questionnaires, and the platform has been used in homeland security applications. The design supports interviewing patients in terrorist incidents to see if they are victims of weapons of mass destruction. The ESP system init
'/>"/>

SOURCE Inclinix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., HUNTERSVILLE, N.C., Nov. 30 M...built-in antimicrobial product protection, is plea...nership with Dal-Tile Corp., the largest U.S. manu...al stone. Dal-Tile Corp is launching two new line...turing Microban(®) patent pending silver base...
(Date:11/30/2009)..., CHICAGO, Nov. 30 Breast-Specifi...hly sensitive imaging technique for the detection ... diagnose breast cancer. BSGI is a molecular breas...nt of tissue density and discover very early stage... the annual meeting of the Radiological Society of...
(Date:11/30/2009)... , BOTHELL, Wash., Nov. 30 /PRNewswire-FirstCa...nced today that on November 25, 2009, the NYSE Ame...t had accepted the Company,s plan to comply with i...ection 1003(a)(iv) of the Exchange Company Guide. ...he Company sustained losses which were so substant...
Breaking Medicine Technology:Dal-Tile Corp. Launches Two New Lines of Ceramic Tile with Microban(R) Silver Antimicrobial Technology 2Breast-Specific Gamma Imaging Proves Highly Sensitive for the Detection of Ductal Carcinoma In Situ 2SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 2SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 3SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 4Pregnancy STDs on the Rise Again Among U S Teens 51972 1Pregnancy STDs on the Rise Again Among U S Teens 51972 2NHP Announces Second Quarter Earnings Release Date and Webcast Conference Call 51969 1NHP Announces Second Quarter Earnings Release Date and Webcast Conference Call 51969 2Justice Department Releases New Fact Sheet on the Rights of Persons With HIV or AIDS to Obtain Occupational Training and State Licensing 51967 1
(Date:12/1/2009)... Caregiving: Ready or Not helps families prepare f... Cincinnati, Ohio (PRWEB) December 2,...ssion to help families understand and embrace the ... hope our loved ones live long, healthy and prospe...e care at some point, and their needs often become...
(Date:12/1/2009)... Free hearing aids will be given by Estes Audiolog... Austin, TX (PRWEB) December 1, 2...a professional hearing healthcare provider dedicat...and their families, announced today the beginning ...way. Each year, Estes Audiology donates two pairs...
(Date:12/1/2009)... Anthony M. Marlon, MD was elected to the Stemedic...) Board of Directors at the Company’s Novemb...(PRWEB) December 1, 2009 -- Anthony M. Marlon, MD ...Inc. (“Stemedica”) Board of Directors .... Roger J. Howe, PhD, Executive Chairman for Steme...
(Date:12/1/2009)...CH, Calif., Dec. 1 To date, hospit...ll reimburse them for the $20 cost of the disposab... for surgery. ,, Anesthesiologists have not tol...void postop dementia from routine anesthesia over-... the ,avoid over-medication, message from their le...
(Date:12/1/2009)... Dec. 1 Cell Therapeut...s presentation at the 21st Annual Piper Jaffray He...00 a.m. Eastern Time will be webcast live at www....ll take place in Holmes 1 at the New York Palace H...the presentation. , , Piper ...
Breaking Medicine News(10 mins):Health News:Aging Expert's New Book Helps Boomers Address Challenges of Caregiving 2Health News:Estes Audiology Offers the Gift of Hearing to Celebrate the Holiday Season 2Health News:Prominent Health Care Executive Joins Stemedica Board Of Directors 2Health News:Prominent Health Care Executive Joins Stemedica Board Of Directors 3Health News:5 Shocking Reasons Your Brain Isn't Worth Twenty Bucks Exposed 2
...la., May 20 Chia Seed Flour is the buzz when it c...hly processed wheat flour. Chia Seed Flour is made...uper food of the Aztec warriors. It is the most nu...r dinner tables everywhere. It is an excellent sou...
... SAN DIEGOPatients with moderate COPD were randomi...disciplinary, community-based program (INTERCOM) t...e of four months, during which patients were instr...tion and smoking cessation. After the four-month ...
...AI, May 20 /PRNewswire-Asia/ -- A Finland Biotech ...ing pharmaceutical R&D outsourcing CRO service... members of the delegation are from Finnish Fundin...a MediTech Company,hosted the group and presented ...
...Y, Mo., May 20 A three-minute video gave Midweste...ture of their region when Kansas City Public Telev...ght rail transit transforms land uses and lifestyl...ted over $6 Billion in smart growth real estate de...
... A Decision A Day Keeps the Doctor A...customers to easily identify health market trends ...e community through more effective profiling of di...ydney, NSW (PRWEB) May 20, 2009 -- The Australian ...
... ACVO®/Merial® National Serv...ring veterinary ophthalmologists with service dogs... Meridian, ID (Vocus) May 20, 2009 -- She ... elated. She completely relies on her guide dog, ...
Other Medicine News:Health News:Nuchia Foods' Gluten-Free Chia Seed Flour Is a Tasty, Low-Fat Alternative Flour 2Health News:Nuchia Foods' Gluten-Free Chia Seed Flour Is a Tasty, Low-Fat Alternative Flour 3Health News:Lifestyle program for patients with COPD is health and cost effective 2Health News:Finland Biotech Delegation Visits Sundia 2Health News:Arnold Imaging Video Generates Public Enthusiasm for Light Rail 2Health News:Innovative Business Intelligence Software Helps Keep Australia Healthy this Winter 2Health News:Innovative Business Intelligence Software Helps Keep Australia Healthy this Winter 3Health News:More Than 1,500 Service Dogs Receive Free Sight Saving Eye Exams 2Health News:More Than 1,500 Service Dogs Receive Free Sight Saving Eye Exams 3Health News:More Than 1,500 Service Dogs Receive Free Sight Saving Eye Exams 4
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
Medicine Products: